Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders Equity

v3.22.1
Condensed Consolidated Statements of Changes in Stockholders Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 2,003 $ 53,064,919 $ 267,948 $ (33,178,517) $ 20,156,353
Shares, Issued at Dec. 31, 2020 20,029,834        
Proceeds from warrants exercised $ 149 3,909,832 3,909,981
Proceeds from warrants exercised, shares 1,488,809        
Common stock issued to settle liabilities $ 47 2,676,854 2,676,901
Common stock issued to settle liabilities, shares 467,990        
Restricted stock awards $ 2 139,998 140,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross 24,476        
Stock based compensation expense 288,968 288,968
Foreign currency translation adjustment (344,088) (344,088)
Net (loss) (609,579) (609,579)
Ending balance, value at Mar. 31, 2021 $ 2,201 60,080,571 (76,140) (33,788,096) 26,218,536
Shares, Issued at Mar. 31, 2021 22,011,109        
Beginning balance, value at Dec. 31, 2021 $ 2,336 66,233,292 (251,083) (48,243,028) 17,741,517
Shares, Issued at Dec. 31, 2021 23,363,732        
Proceeds from open market sales $ 6 131,559 131,565
Proceeds from open market sales, shares 56,472        
Brokers Fees on open market sales (3,949) (3,949)
Restricted stock awards $ 16 424,984 425,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross 162,835        
Stock based compensation expense 597,972 597,972
Foreign currency translation adjustment (151,775) (151,775)
Net (loss) (2,554,216) (2,554,216)
Ending balance, value at Mar. 31, 2022 $ 2,358 $ 67,383,858 $ (402,858) $ (50,797,244) $ 16,186,114
Shares, Issued at Mar. 31, 2022 23,583,039